Smoking and Depression: Targeting Nicotine Receptors To Relieve Depression

Printer-friendly versionPrinter-friendly version
Marina R. Picciotto, Ph.D. Charles B.G. Murphy Professor of Psychiatry, Neurobiology and Pharmacology Yale University 1996 NARSAD Young Investigator Grantee 2004 NARSAD Independent Investigator Grantee, expert on depression
Marina R. Picciotto, Ph.D.

Patients with depression tend to smoke a lot, which led to the idea that nicotine may ease depressive symptoms. Research has shown how the process works. Nicotine binds to particular receptor molecules on the surface of nerve cells in the brain, first activating the receptors, which actually increases depressive symptoms, but then when the receptors turn off, an antidepressant-like effect does seem to follow.

In their normal role the receptors affected by nicotine are receptors for the neurotransmitter acetylcholine, a chemical involved in nerve-cell communication. In the 1970s, a hypothesis of acetylcholine involvement in depression was explored, but it was overshadowed by the introduction of fluoxetine (Prozac®), a selective serotonin reuptake inhibitor (SSRI) that targets the neurotransmitter serotonin. Based on the observations of how the acetylcholine receptor responds to nicotine, researchers hypothesized that if receptor activity could be blocked, it might have a therapeutic effect for patients with depression.

The drug mecamylamine (Inversine®), developed to treat hypertension, is an acetylcholine receptor blocker. In a clinical trial of mecamylamine for depression, patients who had failed to respond to Prozac® or other SSRIs were given mecamylamine along with an SSRI. The results were positive; the combined treatment had an antidepressant effect. The next trial was with a partial agonist, a drug that does not fully block the receptor. Cytosine is a natural product made from the flowers of the laburnum plant. The first trial of cytosine with mice gave the same effect as the full blocker but without the side effect of mecamylamine of severe constipation. Varenicline (ChantixTM) is a drug on the market that works like cytosine and has also shown positive antidepressant effects used in concert with an SSRI.

Before the drug can be introduced for widespread use, another hurdle must be surmounted. As is the case with SSRIs alone, the combined SSRI and acetylcholine receptor blocker can produce an increase in suicidal ideation in a small subset of patients. Researchers are conducting trials to try to identify the patients for whom this treatment would not be advisable. At the same time, other lines of research are seeking to better understand where and how achetylcholine receptor blockers are working in the brain and how the two neurotransmitter systems work together.

Marina R. Picciotto, Ph.D.
Charles B.G. Murphy Professor of Psychiatry, Neurobiology and Pharmacology
Yale University
1996 NARSAD Young Investigator Grantee
2004 NARSAD Independent Investigator Grantee

Article comments

What about using nicotine gum or patch directly? I was diagnosed with depression at age 17 and began taking anti-depressants. I started smoking cigarettes at age 18. For the next 13 years I did not take any medication, but smoked 1-2 packs of cigarettes per day without any depression symptoms and I not only functioned well, but led a successful career.. At age 31 I quit smoking and the depression returned. For the last 20 years I have tried about 20 different medications and combinations of medications without long-term recovery and many unbearable side effects. Even my doctor says this is compelling evidence but is concerned about addiction to nicotine. I was able to quit smoking using a nicotine patch and weaning off of it over about 8 months, so I know first-hand that it is addictive. I ask myself whether nicotine addiction (not cigarettes) is any more harmful than psychotropic drugs that are only partially effective before they stop working and then I have to try a new regimen. I would appreciate any insight or information you may have about using nicotine directly to affect brain receptors and neurotransmitters. Is there any research using nicotine itself to treat depression as an alternative or adjunct to medications?

Great question.

I had a similar experience but would stay awake for 2, 3 or 4 days and sleep one day. I lost 3 businesses during about a ten year period. This went on for years until I started using e cigarettes. The day I started E Cigarettes, I've slept every night since starting and the manic depression has subsided to what I'm guessing is more the norm for the average person. I'm back in business and have regained my life.

Add new comment

comments

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Please note that researchers cannot give specific recommendations or advice about treatment; diagnosis and treatment are complex and highly individualized processes that require comprehensive face-to- face assessment. Please visit our "Ask an Expert" section to see a list of Q & A with NARSAD Grantees.
By submitting this form, you accept the Mollom privacy policy.